Utilizing Advocates and Supporters to Increase Lung Cancer Screening Rates in Eligible Participants

Part of paid clinical trials in Los Angeles, California.

Sponsor
Jonsson Comprehensive Cancer Center
Study ID
NCT05978128
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
40 Years - 80 Years
Healthy Volunteers
Accepted

Interventions

  • Health Education — BEHAVIORAL
    Access electronic patient portal with educational material
  • Health Promotion and Education — OTHER
    Receive materials on breast/lung cancer screening
  • Patient Navigation — BEHAVIORAL
    Interact with a patient navigator
  • Survey Administration — OTHER
    Ancillary studies

Study Details

This clinical trial assesses the use of advocates and supporters of breast and lung cancer screening to increase lung cancer screening rates amongst eligible participants. Imaging-based cancer screening is utilized with variable frequency. Breast cancer screening with mammography has been widely accepted and is commonly used among eligible women. Lung screening with computed tomography scans is poorly used, despite the potential to decrease deaths from lung cancer. There are many reasons lung screening isn't being used when compared to breast screening, such as smoking stigma and fear, along with a lack of awareness of lung screening. By conducting this trial, researchers want to assess the effectiveness of advocates and supporters of breast and lung screening, and to learn about the psychological barriers to cancer screening, identifying those that are unique to lung screening.

Key Dates

Start date
Jul 28, 2023
Status verified
Nov 2025
Primary completion
Sep 30, 2028
Completion
Sep 30, 2029

Study Design

Enrollment
800 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING

Arms

  • Experimental: Screening (electronic patient portal, patient navigation)
    Participants access an electronic patient portal with educational materials at baseline, 1- and 2-year follow-ups, and also interact with a patient navigator on study. Patients also receive materials to share with their friends/family on benefits of breast and lung cancer screening on study.

Primary Outcome Measure

Increased rates of lung and breast cancer screening adherence [ Time Frame: Up to 3 years ]

Locations (1)

FacilityCityStateZIPSite coordinators
UCLA / Jonsson Comprehensive Cancer CenterLos AngelesCalifornia90095
Ashley E. Prosper
[email protected]
310-825-0958
Ashley E. Prosper (PRINCIPAL_INVESTIGATOR)

Find similar trials in Los Angeles, CA

By condition
Breast cancerLung cancer
By specialty
OncologyBreast oncologyWomen's healthLung oncologyLung disease
By research site
UCLA / Jonsson Comprehensive Cancer Center· Los Angeles, CA

Related Studies